Labeler · US market

Aurolife Pharma, LLC

Aurolife Pharma, LLC is a US drug labeler with US FDA registrations covering 23 drug concepts (23 currently active) across 233 packages. It is currently the only active US supplier of 2 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes13107

Active drugs23

Registrations65 active / 68

Packages233

Sole supplier of2 drugs

Portfolio23 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate tablet	rx	7	35	SUPPLYING
Mirtazapine tablet, film coated	rx	4	25	SUPPLYING
Hydrocodone Bitartrate And Acetaminophen tablet	rx	6	24	SUPPLYING
Paroxetine tablet, film coated	rx	4	20	SUPPLYING
Oxycodone And Acetaminophen tablet	rx	4	16	SUPPLYING
Trazodone Hydrochloride tablet	rx	4	16	SUPPLYING
Lorazepam tablet	rx	3	12	SUPPLYING
Hydromorphone Hydrochloride tablet	rx	3	12	SUPPLYING
Acetaminophen And Codeine Phosphate tablet	rx	3	12	SUPPLYING
Clorazepate Dipotassium tablet	rx	6	10	SUPPLYING
Oxycodone Hydrochloride tablet	rx	3	9	SUPPLYING
Methadone Hydrochloride tablet	rx	2	6	SUPPLYING
Oxymorphone Hydrochloride tablet	rx	2	6	SUPPLYING
Dextroamphetamine Sulfate tablet	rx	2	6	SUPPLYING
Phentermine Hydrochloride capsule	rx	2	4	SUPPLYING
Hydrocodone Bitartrate And Ibuprofen tablet, film coated	rx	1	4	SUPPLYING
Phentermine Hydrochloride tablet	rx	1	3	SUPPLYING
Butalbital, Acetaminophen And Caffeine capsule	rx	1	3	SUPPLYING
Methylphenidate Hydrochloride tablet	rx	3	3	SUPPLYING
Oxycodone Hydrochloride Oral Solution solution	rx	2	2	SUPPLYING
Glycopyrrolate tablet	rx	2	2	SUPPLYING
Amphetamine Sulfate tablet	rx	2	2	SUPPLYING
Diclofenac Sodium solution	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

At a glance

TypeLabeler
Labeler codes13107
Filing names1
Drugs (active)23
Drugs (all time)23
US registrations68
Packages233

Recent events

Shortages, recalls, and registration changes across all filing names.

Apr 24, 2024
RECALLRecall (Class II): Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) 100 tablets per bottle, NDC 13107-282-01 b) 500 tablets per bottle, N…
Apr 24, 2024
RECALLRecall (Class II): Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, N…
May 18, 2023
RECALLRecall (Class III): Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor…
Dec 16, 2022
RECALLRecall (Class II): Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 0…
Oct 12, 2022
SHORTAGEDrug shortage: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (Aurobindo Pharma USA)
Mar 17, 2022
RECALLRecall (Class II): Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton…
Mar 18, 2020
RECALLRecall (Class II): Acetaminophen and Codeine Phosphate Tablets, USP, 300 mg/15 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo P…
Mar 18, 2020
RECALLRecall (Class II): Oxycodone and Acetaminophen Tablets, USP 10 mg*/325 mg 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.